Details for Patent: 6,900,175
✉ Email this page to a colleague
Which drugs does patent 6,900,175 protect, and when does it expire?
Patent 6,900,175 protects DALVANCE and is included in one NDA.
This patent has fifty-eight patent family members in twenty countries.
Summary for Patent: 6,900,175
Title: | Methods of administering dalbavancin for treatment of bacterial infections |
Abstract: | The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection. |
Inventor(s): | Cavaleri; Marco (Saronno, IT), Jabes; Daniela (Cassina Rizzardi, IT), Henkel; Timothy (Berwyn, PA), Malabarba; Adriano (Buccinasco, IT), Mosconi; Giorgio (Malvern, PA), Stogniew; Martin (Blue Bell, PA), White; Richard J. (Emeryville, CA) |
Assignee: | Vicuron Pharmaceuticals Inc. (King of Prussia, PA) |
Application Number: | 10/714,261 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 6,900,175
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | DALVANCE | dalbavancin hydrochloride | POWDER;INTRAVENOUS | 021883-001 | May 23, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) IN ADULT AND PEDIATRIC PATIENTS USING A TWO-DOSE REGIMEN OF DALBAVANCIN | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,900,175
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2003294262 | ⤷ Try a Trial | |||
Australia | 2003298662 | ⤷ Try a Trial | |||
Australia | 2003299561 | ⤷ Try a Trial | |||
Australia | 2005325261 | ⤷ Try a Trial | |||
Australia | 2011200423 | ⤷ Try a Trial | |||
Brazil | PI0510269 | ⤷ Try a Trial | |||
Canada | 2506236 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |